New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Cholangiocarcinoma Pipeline Analysis | Insights into the Latest FDA, EMA, and PM
- 1
- 1
- 2 years, 2 months ago
- Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization
- 1
- 1
- 2 years, 2 months ago
- The Clinical Landscape of Cell-Free DNA Alterations in 1,671 Patients with Advan
- 1
- 1
- 2 years, 2 months ago
- A Case Report of Primary Unresectable Hilar Cholangiocarcinoma Causing Colonic O
- 1
- 1
- 2 years, 2 months ago
- Intrahepatic sarcomatoid cholangiocarcinoma: a rare cholangiocarcinoma subtype
- 1
- 1
- 2 years, 2 months ago
- The Clinical Landscape of Cell-Free DNA Alterations in 1,671 Patients with Advan
- 1
- 1
- 2 years, 2 months ago
- Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic i
- 1
- 1
- 2 years, 2 months ago
- Comprehensive germline and somatic genomic profiles of Chinese patients with bil
- 1
- 1
- 2 years, 2 months ago
- [The clinical value of classification of hilar cholangiocarcinoma based on actua
- 1
- 1
- 2 years, 2 months ago
- The forum ‘New Developments’ is closed to new topics and replies.